No Data
No Data
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
PaxMedica today announced it has timely filed a formal notice of appeal with the Nasdaq Office of Appeals and Review to reverse the decision of a Nasdaq Hearings Panel to delist the Company from Nasdaq.
Express News | PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on Pax-101
PaxMedica | 10-Q: Quarterly report
Express News | PaxMedica Provides Company Update and Continues to Advance Pax-101 Regulatory Strategy
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy
PaxMedica, Inc. (OTC:PXMD) provided a corporate update in light of its transition off the NASDAQ stock market, emphasizing this change will not affect the company's commitment to advancing treatments for neurological disorders.
Express News | PaxMedica - on April 30, Nasdaq Stock Market Notified Co Trading of Co’s Securities Will Be Suspended at Open of Trading on May 2
No Data